"Leishmaniasis, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Descriptor ID |
D016773
|
| MeSH Number(s) |
C03.752.300.500.400 C03.858.560.400 C17.800.838.775.560.400
|
| Concept/Terms |
Oriental Sore- Oriental Sore
- Sore, Oriental
- Leishmaniasis, Old World
- Old World Leishmaniasis
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Cutaneous".
This graph shows the total number of publications written about "Leishmaniasis, Cutaneous" by people in this website by year, and whether "Leishmaniasis, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Cutaneous" by people in Profiles.
-
Trufant JW, Lewin JM, Hale CS, Meehan SA, Pomeranz MK. New world cutaneous leishmaniasis. Dermatol Online J. 2014 Dec 16; 20(12).
-
Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, Cooper AM, Yap GS, Arditi M, Shimada K, Duhadaway JB, Prendergast GC, Basaraba RJ, Mellor AL, Munn DH, Aliberti J, Karp CL. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis. 2012 Jan 01; 205(1):152-61.
-
Sinagra A, Luna C, Abraham D, Iannella Mdel C, Riarte A, Krolewiecki AJ. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model. Rev Soc Bras Med Trop. 2007 Nov-Dec; 40(6):627-30.
-
Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Am J Trop Med Hyg. 2007 Oct; 77(4):640-6.
-
Krolewiecki AJ, Leon S, Scott PA, Nolan TJ, Schad GA, Abraham D. Effect of chronic ethanol consumption on protective T-helper 1 and T-helper 2 immune responses against the parasites Leishmania major and Strongyloides stercoralis in mice. Alcohol Clin Exp Res. 2001 Apr; 25(4):571-8.
-
Oumeish OY, Parish LC. Cutaneous leishmaniasis (CL) is an important public health problem in many countries. Clin Dermatol. 1999 May-Jun; 17(3):247-8.